These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24795921)

  • 1. Team demonstrates the rational design of drugs from RNA sequence.
    Coaker H
    Future Med Chem; 2014 Apr; 6(5):495. PubMed ID: 24795921
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
    Gao F; Wang W
    Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
    Disney MD; Angelbello AJ
    Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
    Xu D; He X; Chang Y; Xu C; Jiang X; Sun S; Lin J
    Oncol Rep; 2013 Feb; 29(2):653-61. PubMed ID: 23151657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type phylogenetics and the origin of endometrial stromal cells.
    Kin K; Nnamani MC; Lynch VJ; Michaelides E; Wagner GP
    Cell Rep; 2015 Mar; 10(8):1398-409. PubMed ID: 25732829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a forkhead transcription factor, FOXO1A, in UV-induced changes of collagen metabolism.
    Tanaka H; Murakami Y; Ishii I; Nakata S
    J Investig Dermatol Symp Proc; 2009 Aug; 14(1):60-2. PubMed ID: 19675556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-specific microRNA regulation of FOXO1: implications for microRNA recognition element evolution.
    McLoughlin HS; Wan J; Spengler RM; Xing Y; Davidson BL
    Hum Mol Genet; 2014 May; 23(10):2593-603. PubMed ID: 24368418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of forkhead box protein O1 (FoxO1) in alcohol-induced intestinal barrier dysfunction.
    Wang Y; Tong J; Zou D; Chang B; Wang B; Wang B
    Acta Histochem; 2013 Jul; 115(6):557-63. PubMed ID: 23347700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
    Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
    Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-based design of bioactive small molecules that target precursor microRNAs.
    Velagapudi SP; Gallo SM; Disney MD
    Nat Chem Biol; 2014 Apr; 10(4):291-7. PubMed ID: 24509821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function.
    Jadhav VM; Scaria V; Maiti S
    Angew Chem Int Ed Engl; 2009; 48(14):2557-60. PubMed ID: 19229913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs.
    Yang M; Mattes J
    Pharmacol Ther; 2008 Jan; 117(1):94-104. PubMed ID: 17928059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One long oligonucleotide or two short oligonucleotides based shRNA construction and expression.
    Wang XJ; Wang SQ
    Methods Mol Biol; 2015; 1218():37-41. PubMed ID: 25319644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of 2'-O-Me RNA/ENA chimera oligonucleotides to induce exon skipping in dystrophin pre-mRNA.
    Takagi M; Yagi M; Ishibashi K; Takeshima Y; Surono A; Matsuo M; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):297-8. PubMed ID: 17150596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of siRNAs with 2-thio-2'-O-methyluridine modification in mammalian cells.
    Prakash TP; Naik N; Sioufi N; Bhat B; Swayze EE
    Nucleosides Nucleotides Nucleic Acids; 2009 Oct; 28(10):902-10. PubMed ID: 20183560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly accurate synthesis of the fully 2'-fluoro-modified oligonucleotide by Therminator DNA polymerases.
    Kasuya T; Hori S; Hiramatsu H; Yanagimoto T
    Bioorg Med Chem Lett; 2014 May; 24(9):2134-6. PubMed ID: 24703229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispyrene-conjugated 2'-O-methyloligonucleotide as a highly specific RNA-recognition probe.
    Mahara A; Iwase R; Sakamoto T; Yamana K; Yamaoka T; Murakami A
    Angew Chem Int Ed Engl; 2002 Oct; 41(19):3648-50, 3518. PubMed ID: 12370918
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of oligonucleotides with glucosamine at the 3'-position and evaluation of their biological activity.
    Luo X; Sugiura T; Nakashima R; Kitamura Y; Kitade Y
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4157-61. PubMed ID: 23743279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shape space. Is biopharmaceutical discovery entering a new evolutionary stage?
    Edgington SM
    Biotechnology (N Y); 1993 Mar; 11(3):285-9. PubMed ID: 7680208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.